HIQA inspection notes residents are well supported by staff
A Cavan designated centre for adults with disabilities has been found compliant across eight sections of the Health…
HIQA Reports published on a number of HSE facilities in Sligo
The HSE have recommended a number of actions following an inspection of a Sligo Health Service Executive facility.…
Men’s Health: Why Silence And Hustle Culture Are Costing Lives
This week on NDTV Lifeline, the focus is on a subject too often ignored: men’s health. Despite advances…
How Ghana Slashed Child Malaria Deaths By 86%
Ghana has combined the malaria vaccine with other proven tools, including using trusted voices to counter misinformation. For…
29-year-old doctor has $1.2 million invested before finishing residency
This story is part of CNBC Make It’s Millennial Money series, which examines how people earn, spend and…
Generative AI-enabled clinical decision support system in primary care: a pragmatic, cluster-randomized trial
Design We conducted a pragmatic, multicenter, parallel-group cluster-randomized controlled trial across a network of 16 primary care facilities…
Why Eli Lilly is collaborating with Oura
Eli Lilly’s LillyDirect is trying on a new accessory. On Tuesday, the pharmaceutical company’s digital healthcare platform announced…
Chink in the armour: How surgical gloves exposed gaps in medical device procurement process – The South First
Maharashtra Food and Drug Administration found that surgical gloves supplied to government hospitals have not undergone proper sterilisation…
Mayo patients ‘paying the price for hospital under-investment’
“The emergency department is now seeing more than 41,000 patients a year despite being built to deal with…
Sláintecare and the loss of income from private patients – The Irish Times
Sir, – Sam Coulter-Smith (Letters, June 24th) suspects that one of the unintended consequences of Sláintecare is that…
Mark Tame obituary | Health
My friend Mark Tame, who has died of lung cancer aged 61, spent his life caring for others.…
J&J CEO Now Sees ‘Line of Sight’ to Double-Digit Growth for His $100 Billion Company. Here’s Why Investors Should Pay Attention.
Johnson & Johnson (JNJ +3.45%) is one of the most recognized names in the healthcare sector. It is…